Pharmaceutical manufacturing quality experts are essential professionals who ensure that every drug produced adheres to strict quality standards and regulatory requirements. Their responsibilities include overseeing the entire manufacturing process, from raw material inspection to final product release, to guarantee that medications are safe, effective, and consistent. These experts implement and monitor compliance with Good Manufacturing Practices (GMP), conduct thorough quality control testing, and validate production processes. By identifying and addressing deviations, contamination risks, or batch inconsistencies early on, they help prevent costly recalls and protect patient health. Their vigilance is crucial in maintaining the trust of regulatory bodies and consumers alike.
In addition to regulatory compliance, pharmaceutical manufacturing quality experts play a vital role in continuous process improvement. They analyze production data to detect trends and potential issues, developing corrective and preventive actions (CAPA) to enhance product quality and manufacturing efficiency. Collaboration with research and development, production teams, and regulatory affairs is key to integrating new technologies and innovations without compromising quality. With the increasing complexity of drug formulations and manufacturing methods, these experts are also pivotal in managing risk assessments and ensuring robust documentation throughout the production lifecycle. Ultimately, pharmaceutical manufacturing quality experts uphold the standards that enable safe, reliable medicines to reach patients worldwide.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico